Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-345

The FDA already demonstrated clearly in the Ryoncil decision they are not bothered by numbers of deaths.
So lets put that right to bed.

While Covid is enormous world wide, I'm not convinced this animal can change it's spots easily. But my biggest fear arises from being lulled by posters into believing MSB management had a special entree and understanding with the FDA via Silviu, going back 10 years. And why wouldn't we given all the other expensive US based suits, Burns, Swedish, Spooner etc we have on the BOD with huge career experience in Medical and Pharma.
Why do we need those fees but for a lot of expert guidance and consultations?
There is nothing special about our FDA relationship that I can detect.

And now something really stinks. Ryoncil tells me there are hidden hands somewhere around the table, when approval was almost certain? FDA wise nothing will ever be certain to me for our virtually unknown Aussie company.